Breadcrumb
NIH Guide: Weekly Index for April 24, 2020
Weekly NIH Funding Opportunities and Notices
April 24, 2020
General Notices
-
Frequently Asked Questions for NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
(NOT-AG-20-031)National Institute on Aging
-
Pre-Application Webinar for RFA-CA-20-031, Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)
(NOT-CA-20-055)National Cancer Institute
Notice of Changes to Funding Opportunities
-
Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19
(NOT-DC-20-006)National Institute on Deafness and Other Communication Disorders
-
Notice to Amend NOT-DK-20-016, Notice of Early Expiration of NIDDK R21 Funding Opportunity Announcements and Restore the Original Key Dates for PAR-18-857 and PAR-19-222
(NOT-DK-20-025)National Institute of Diabetes and Digestive and Kidney DiseasesNational Cancer Institute
-
Notice of NCATS Withdrawal from Participation in PAR-18-690, Innovative Therapies and Tools for Screenable Disorders in Newborns (R03 Clinical Trial Optional)
(NOT-TR-20-023)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Notice of NCATS Withdrawal from Participation in PAR-18-689, Innovative Therapies and Tools for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
(NOT-TR-20-024)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Special Interest
-
Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults
(NOT-DA-20-014)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Availability of Administrative Supplements to Diversify the NIDDK Clinical Trial Workforce
(NOT-DK-20-021)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Special Interest (NOSI): Availability of Administrative Supplements to NIDDK STEP-UP Centers for Increased Outreach
(NOT-DK-20-022)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Special Interest: Administrative Supplements for Research on Ethical, Legal and Social Issues regarding Post-mortem Pediatric Tissue Procurement for Research Purposes (Admin Supp Clinical Trial Optional)
(NOT-HD-20-012)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research Institute
-
HEAL Initiative: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements to Support Strategies to Reduce Stigma in Pain Management and Opioid Use Disorder (OUD) and Treatment
(NOT-OD-20-101)Office of Behavioral and Social Sciences ResearchNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthOffice of Disease Prevention
-
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
(NOT-TR-20-028)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Funding Opportunities
-
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(PA-20-166)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesJohn E. Fogarty International CenterNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational SciencesDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Due dates vary by awarding IC Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
(PA-20-171)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Standard dates apply. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)
(PA-20-172)National Institute on Minority Health and Health DisparitiesNational Institute on AgingNational Cancer InstituteNational Institute on Drug AbuseApplication Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 5, 2020.
-
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
(PA-20-173)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Standard dates apply. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)
(PA-20-174)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Standard dates apply. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 - Clinical Trial Optional)
(PAR-20-175)National Institute of General Medical SciencesApplication Receipt Date(s): October 7, 2020; October 7, 2021, and October 7, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed).
(RFA-AI-20-027)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): October 9, 2020
-
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
(RFA-RM-20-019)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): July 15, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: March 19, 2025
For technical issues E-mail OER Webmaster